Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoqing Fu

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Gut|April 11, 2026
Tryptophan depletion generates hyper-reactive portal neutrophils in alcoholic liver diseaseSara Reinartz Groba, Mathis Richter, Dennis Schwarz, et al.
Blood|December 14, 2021
Platelet ACKR3/CXCR7 favors antiplatelet lipids over an atherothrombotic lipidome and regulates thromboinflammationMalgorzata Cebo, Kristina Dittrich, Xiaoqing Fu, et al.
Frontiers in Microbiology|October 31, 2022
Highly diverse ribonucleic acid viruses in the viromes of eukaryotic host species in Yunnan province, ChinaZhenzhi Han, Jinbo Xiao, Yang Song, et al.
Arthritis Care & Research|March 21, 2022
Assessing the Severity of COVID-19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning-Derived Chest Radiograph ScoresNaomi J Patel, Kristin M D'Silva, Matthew D Li, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective studyMichael Di Iorio, Claire E Cook, Kathleen M M Vanni, et al.
Seminars in Arthritis and Rheumatism|May 26, 2022
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective studyMichael Di Iorio, Claire E Cook, Kathleen M M Vanni, et al.
The Lancet. Rheumatology|June 7, 2021
Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort studyTiffany Y-T Hsu, Kristin M D'Silva, Naomi J Patel, et al.
The Lancet. Rheumatology|February 27, 2023
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort studyGrace Qian, Xiaosong Wang, Naomi J Patel, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2022
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort studyGrace Qian, Xiaosong Wang, Naomi J Patel, et al.
The Lancet. Rheumatology|January 23, 2024
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trialJennifer S Hanberg, Xiaoqing Fu, Xiaosong Wang, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Gut|April 11, 2026
Tryptophan depletion generates hyper-reactive portal neutrophils in alcoholic liver diseaseSara Reinartz Groba, Mathis Richter, Dennis Schwarz, et al.
Blood|December 14, 2021
Platelet ACKR3/CXCR7 favors antiplatelet lipids over an atherothrombotic lipidome and regulates thromboinflammationMalgorzata Cebo, Kristina Dittrich, Xiaoqing Fu, et al.
Frontiers in Microbiology|October 31, 2022
Highly diverse ribonucleic acid viruses in the viromes of eukaryotic host species in Yunnan province, ChinaZhenzhi Han, Jinbo Xiao, Yang Song, et al.
Arthritis Care & Research|March 21, 2022
Assessing the Severity of COVID-19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning-Derived Chest Radiograph ScoresNaomi J Patel, Kristin M D'Silva, Matthew D Li, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective studyMichael Di Iorio, Claire E Cook, Kathleen M M Vanni, et al.
Seminars in Arthritis and Rheumatism|May 26, 2022
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective studyMichael Di Iorio, Claire E Cook, Kathleen M M Vanni, et al.
The Lancet. Rheumatology|June 7, 2021
Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort studyTiffany Y-T Hsu, Kristin M D'Silva, Naomi J Patel, et al.
The Lancet. Rheumatology|February 27, 2023
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort studyGrace Qian, Xiaosong Wang, Naomi J Patel, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2022
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort studyGrace Qian, Xiaosong Wang, Naomi J Patel, et al.
The Lancet. Rheumatology|January 23, 2024
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trialJennifer S Hanberg, Xiaoqing Fu, Xiaosong Wang, et al.
Pageof 16